A phenotypic-based drug screening carried on induced pluripotent stem cells (iPSCs) from sporadic ALS patients demonstrated that more than half of the screened hits targeted the Src/c-Abl signalling pathway. Here, ABL1 is linked to amyotrophic lateral sclerosis.